ALLMedicine™ Cardiogenic Shock Center

Mar 19th, 2023 - Pulsatile-flow veno-arterial extracorporeal membrane oxygenation (V-A ECMO) has shown encouraging results for microcirculation resuscitation and left ventricle unloading in patients with refractory cardiogenic shock. We aimed to comprehensively as...

Mar 18th, 2023 - There is increasing evidence on the role of ultrasound in the evaluation of multi-organ hypoperfusion and congestion in patients with cardiocirculatory shock both to identify the underlying pathophysiological mechanism, to drive and monitor the tr...

Mar 18th, 2023 - Cardiogenic shock (CS) is a common cause of death following acute myocardial infarction (MI). This study aimed to evaluate the adjusted mortality of venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon counterpulsat...

Mar 16th, 2023 - Temporary mechanical circulatory support (MCS) encompasses a wide array of invasive devices, which provide short-term hemodynamic support for multiple clinical indications. Although initially developed for the management of cardiogenic shock, indi...

Mar 16th, 2023 - Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has bee...

Mar 3rd, 2023 - Cardiogenic shock (CS) defines a state of systemic hypo-perfusion leading to end-organ dysfunction related to cardiac pump failure and with mortality rates in the range of 27-50% according to recent reviews. Patients with CS often received mechani...

Mar 2nd, 2023 - Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, tempora...

Mar 1st, 2023 - LUS-AMI is an observational cohort prospective study that evaluates the prognostic value of lung ultrasound, specifically the number of B-lines, performed within the first 24 hours after and ST-segment elevation acute myocardial infarction, by an ...

Mar 1st, 2023 - Open-label, multicenter, randomized, controlled trial. This study will be conducted in patients with cardiogenic shock or acute respiratory distress syndrome receiving percutaneous ECMO for less than 24h. All consecutive eligible patients will be ...

Mar 1st, 2023 - Venoarterial (VA) ECMO is a form of life support for patients with severe cardiogenic shock and cardiac arrest. Although it can be lifesaving, currently many patients still die or have long term disability, such as weakness, shortness of breath an...

Mar 1st, 2023 - Women continue to have a higher risk of mortality and morbidity after coronary artery bypass grafting (CABG) compared with men, with no significant improvements seen over the last decade, a retrospective cohort study found. Among over 1.2 million ...

Feb 28th, 2023 - Meta-analysis makes the case for insomnia as a risk factor for myocardial infarction. (Clinical Cardiology) Outpatient procedures associated with postoperative heart attacks included gastrointestinal endoscopy, as well as vascular, urological/gyne...

Dec 7th, 2022 - The exploration started in 2004 with a 62-year-old man who presented to an emergency department with acute shortness of breath, tachycardia with chest discomfort, and light-headedness, Amado Alejandro Baez, MD, said in a presentation at the Americ...

Nov 6th, 2022 - Routine early, expeditious use of extracorporeal membrane oxygenation (ECMO) is a common strategy in patients with severe cardiogenic shock, but a less aggressive initial approach may be just as effective, a randomized trial suggests. In the study...

Oct 17th, 2022 - The US Food and Drug Administration has granted 510(k) clearance for Abiomed's Impella Low Profile Sheath used to place and manage Impella heart pumps. "The Low Profile Sheath is the first sheath specifically engineered to be compatible with the I...